Table 2.
Clinical impact: description of cohort and medication administration. “Differential RR” is the relative risk of receiving a medication in the high-delirium-risk group after AWOL-S implementation, after controlling for secular trends using rates of medication use in the low-risk group.
| Baseline | AWOL-S | p | |||||
|---|---|---|---|---|---|---|---|
| Low risk | High risk | Low risk | High risk | Before vs after AWOL-S | |||
| Number of surgical encounters | 7,368 | 2,049 | 13,704 | 3,630 | |||
| Age (years) | 53 ± 16 | 67 ± 12 | 53 ± 16 | 68 ± 12 | 0.85 | ||
| Unable to spell WORLD backward | 10% | 35% | 13% | 38% | <0.001 | ||
| Not oriented to place | 2.5% | 15% | 1.7% | 13% | <0.001 | ||
| High illness severity | (ASA 3+) | 29% | 77% | 29% | 76% | 0.12 | |
| Surgery-specific delirium risk | Low | 74% | 7.4% | 74% | 7.1% | 0.32 | |
| Moderate | 23% | 70% | 23% | 70% | |||
| High | 2.6% | 23% | 3.0% | 23% | |||
| Delirium in first 7 postop days | 1.3% | 10% | 1.3% | 11.4% | 0.31 | ||
| Perioperative medication use | Differential RR | p | |||||
| Any benzodiazepine | 54% | 37% | 50% | 33% | 0.95 [0.88–1.03] | 0.24 | |
| Midazolam | 54% | 36% | 50% | 32% | 0.95 [0.87–1.03] | 0.19 | |
| Lorazepam | 1.8% | 2.0% | 1.7% | 1.8% | 0.98 [0.63–1.53] | 0.63 | |
| Any anticholinergic | 12% | 8.6% | 12% | 6.5% | 0.79 [0.64–0.97] | 0.02 | |
| Diphenhydramine | 1.7% | 1.5% | 2.2% | 1.4% | 0.74 [0.45–1.22] | 0.23 | |
| Meperidine | 2.8% | 2.0% | 3.9% | 1.9% | 0.68 [0.45–1.03] | 0.07 | |
| Prochlorperazine | 6.6% | 4.5% | 5.1% | 3.1% | 0.89 [0.67–1.19] | 0.44 | |
| Promethazine | 0.1% | 0.1% | 0.06% | 0.03% | 0.52 [0.04–7.01] | 0.63 | |
| Scopolamine | 2.1% | 1.1% | 1.7% | 0.6% | 0.72 [0.39–1.34] | 0.31 | |